RecruitingNANCT07084779

Investigation of Impact of AI on Prostate Cancer Workflow

Sponsor: Case Comprehensive Cancer Center

Trial Details

Condition	Prostate Cancer, Prostatic Neoplasm, Cancer of the Prostate, Neoplasms, Prostate
Intervention	AI
Phase	NA
Status	Recruiting
Participants	150
Est. Completion	30 Nov 2026
Last Updated	15 May 2026

Primary Outcome

Readers' (radiologists') mean quadrant-level area under the receiver operating characteristic curve (AUC) in predicting the presence or absence of clinically significant prostate cancer (csPCa)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Plan of care is to undergo a biopsy of the prostate after a pre-biopsy MRI * Age 55-80 * Prostate-specific antigen (PSA) between 3-10 ng/mL * No prior diagnosis or treatment of prostate cancer Exclusion Criteria: * Pre-biopsy MRI is of low quality * PI-QUAL score of 1 using PI-QUAL version 2

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Multicentre Trial Evaluates AI-Assisted MRI Interpretation for Prostate Cancer Detection — Implications for Radiology Workflow

New US trial evaluates AI-assisted MRI interpretation for prostate cancer detection, comparing radiologist performance with and without artificial intelligence support. Results could transform prostate imaging workflows globally.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service